Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 5, 2007, Pages 1155-1158

  Anderson, Ronald ^a   Steel, H C ^a   Cockeran, R ^a   von Gottberg, A ^b   de Gouveia, L ^b   Klugman, K P ^b,c   Mitchell, T J ^d   Feldman, C ^e  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Macrolide resistance; Pneumococcus; Protein synthesis

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CALCIUM ION; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; MACROLIDE; MOXIFLOXACIN; PNEUMOLYSIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TELITHROMYCIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CALCIUM TRANSPORT; CONTROLLED STUDY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NEUTROPHIL; NONHUMAN; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CEFTRIAXONE; DOXYCYCLINE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS; TOBRAMYCIN;

EID: 35448968988     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm338     Document Type: Article

References (10)

1. Lagrou K, Peetermans WA, Jorrisen M et al. Subinhibitory concentrations of erythromycin reduce pneumococcal adherence to respiratory epithelial cells in vitro. J Antimicrob Chemother 2000; 46: 717-23.
2. Fukuda Y, Yanagihara K, Higashiyama Y et al. Effects of macrolides against pneumolysin of macrolide-resistant Streptococcus pneumoniae. Eur Respir J 2006; 27: 1020-5.
3. Anderson R, Steel HC, Cockeran R et al. Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae. J Antimicrob Chemother 2007; 59: 224-9.
4. Musher DM, Phan HM, Baughn RE. Protection against bacteremic pneumococcal infection by antibody to pneumolysin. J Infect Dis 2001; 183: 827-30.
5. Ichimiya T, Yamasaki T, Nasu M. In-vitro effects of antimicrobial agents on Pseudomonas aeruginosa biofilm formation. J Antimicrob Chemother 1994; 34: 331-41.
6. Wozniak DJ, Keyser R. Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa. Chest 2004; 125 Suppl 2: 62S-9S.
7. Tateda K, Standiford TJ, Pechere JC et al. Regulatory effects of macrolides on bacterial virulence. Curr Pharm Res 2004; 10: 3055-65.
8. Naka Y, Jansch L, Bredenbruch F et al. Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PA01: A global approach. Antimicrob Agents Chemother 2006; 50: 1680-8.
9. MacFarlane JT, Boswell T, Douglas G et al. British Thoracic Society guidelines for the management of community-acquired pneumonia in adults. Thorax 2001; 56: 1-64.
10. Waterer GW. Monotherapy versus combination therapy for pneumococcal pneumonia. Curr Opin Infect Dis 2005; 18: 157-63.